Price target upside
Vistagen Therapeutics, Inc. Price Target Upside or Downside
VTGN price target upside based on the current price and analyst average.
Direct answer
Vistagen Therapeutics, Inc.'s analyst target implies +282.8%.
The average target is $1.00 compared with a recorded current price of $0.26.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 13, 2026.
Get free Vistagen Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.26
- Average price target
- $1.00
- High price target
- $1.00
- Low price target
- $1.00
- Target upside
- +282.8%
- Consensus rating
- Hold
- Analysts
- 2
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026